BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18041590)

  • 1. Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.
    Lubensky IA; Zhuang Z
    Endocr Pathol; 2007; 18(3):156-62. PubMed ID: 18041590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
    Rindi G; Bordi C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
    Rindi G; Villanacci V; Ubiali A
    Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
    Oberg K
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):72-8. PubMed ID: 19115524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
    Rindi G; Candusso ME; Solcia E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation.
    Tönnies H; Toliat MR; Ramel C; Pape UF; Neitzel H; Berger W; Wiedenmann B
    Gut; 2001 Apr; 48(4):536-41. PubMed ID: 11247899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
    Girardi DM; Silva ACB; Rêgo JFM; Coudry RA; Riechelmann RP
    Cancer Treat Rev; 2017 May; 56():28-35. PubMed ID: 28456055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
    Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
    Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation.
    Fujii T; Kawai T; Saito K; Hishima T; Hayashi Y; Imura J; Hironaka M; Hosoya Y; Koike M; Fukayama M
    Pathol Int; 1999 Nov; 49(11):968-73. PubMed ID: 10594843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
    Chetty R
    Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
    Arakelyan J; Zohrabyan D; Philip PA
    Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
    Arnold CN; Sosnowski A; Blum HE
    Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumors: pathologic and molecular characteristics.
    Shi C; Klimstra DS
    Semin Diagn Pathol; 2014 Nov; 31(6):498-511. PubMed ID: 25441311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
    Larsson C
    Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
    Pape UF; Höcker M; Seuss U; Wiedenmann B
    Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
    Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
    Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights of the biology of endocrine tumours of the gut and pancreas.
    Rindi G; Bordi C
    Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Sigel CS
    Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors.
    Guo SS; Arora C; Shimoide AT; Sawicki MP
    Mol Cell Endocrinol; 2002 Apr; 190(1-2):109-14. PubMed ID: 11997184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.